These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26920997)
1. Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis. Municio C; Soler Palacios B; Estrada-Capetillo L; Benguria A; Dopazo A; García-Lorenzo E; Fernández-Arroyo S; Joven J; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A Ann Rheum Dis; 2016 Dec; 75(12):2157-2165. PubMed ID: 26920997 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism. Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121 [TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity. Borman P; Taşbaş Ö; Karabulut H; Tukun A; Yorgancıoğlu R Rev Bras Reumatol; 2015; 55(6):485-92. PubMed ID: 25687398 [TBL] [Abstract][Full Text] [Related]
4. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue. Stamp LK; Hazlett J; Highton J; Hessian PA J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048 [TBL] [Abstract][Full Text] [Related]
5. The effects of low-dose methotrexate on thymidylate synthetase activity in human peripheral blood mononuclear cells. Hornung N; Stengaard-Pedersen K; Ehrnrooth E; Ellingsen T; Poulsen JH Clin Exp Rheumatol; 2000; 18(6):691-8. PubMed ID: 11138330 [TBL] [Abstract][Full Text] [Related]
6. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Ronda N; Greco D; Adorni MP; Zimetti F; Favari E; Hjeltnes G; Mikkelsen K; Borghi MO; Favalli EG; Gatti R; Hollan I; Meroni PL; Bernini F Arthritis Rheumatol; 2015 May; 67(5):1155-64. PubMed ID: 25605003 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695 [TBL] [Abstract][Full Text] [Related]
8. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. van der Heijden JW; Oerlemans R; Tak PP; Assaraf YG; Kraan MC; Scheffer GL; van der Laken CJ; Lems WF; Scheper RJ; Dijkmans BA; Jansen G Arthritis Rheum; 2009 Mar; 60(3):669-77. PubMed ID: 19248091 [TBL] [Abstract][Full Text] [Related]
9. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444 [TBL] [Abstract][Full Text] [Related]
10. TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis. Bae SC; Lee YH Z Rheumatol; 2018 Nov; 77(9):824-832. PubMed ID: 29380036 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Blits M; Jansen G; Assaraf YG; van de Wiel MA; Lems WF; Nurmohamed MT; van Schaardenburg D; Voskuyl AE; Wolbink GJ; Vosslamber S; Verweij CL Arthritis Rheum; 2013 Nov; 65(11):2791-802. PubMed ID: 23897011 [TBL] [Abstract][Full Text] [Related]
12. The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis. Fuentelsaz-Romero S; Barrio-Alonso C; García Campos R; Torres Torresano M; Muller IB; Triguero-Martínez A; Nuño L; Villalba A; García-Vicuña R; Jansen G; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A Front Immunol; 2021; 12():776879. PubMed ID: 34804067 [TBL] [Abstract][Full Text] [Related]
14. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036 [TBL] [Abstract][Full Text] [Related]
15. Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors α and β: correlation with methotrexate efficacy in rheumatoid arthritis patients. Gatica H; Aliste M; Guerrero J; Goecke IA Rheumatology (Oxford); 2011 Sep; 50(9):1665-71. PubMed ID: 21642336 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages. Muller IB; Lin M; de Jonge R; Will N; López-Navarro B; van der Laken C; Struys EA; Oudejans CBM; Assaraf YG; Cloos J; Puig-Kröger A; Jansen G Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298590 [TBL] [Abstract][Full Text] [Related]
17. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. Soler Palacios B; Estrada-Capetillo L; Izquierdo E; Criado G; Nieto C; Municio C; González-Alvaro I; Sánchez-Mateos P; Pablos JL; Corbí AL; Puig-Kröger A J Pathol; 2015 Feb; 235(3):515-26. PubMed ID: 25319955 [TBL] [Abstract][Full Text] [Related]
18. Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients. Hirohata S; Yanagida T; Tomita T; Yoshikawa H Int Immunopharmacol; 2009 Jan; 9(1):86-90. PubMed ID: 19000788 [TBL] [Abstract][Full Text] [Related]
19. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis. Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894 [TBL] [Abstract][Full Text] [Related]
20. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]